Triptolide Inhibits the Proliferation of HaCaT Cells Induced by IL22 via Upregulating miR-181b-5p

References

• ZhaoX, LiR, QiaoM, YanJ, SunQ. MiR-548a-3p promotes keratinocyte proliferation targeting PPP3R1 after being induced by IL22. Inflammation. 2018;41(2):496–504. doi:10.1007/s10753-017-0705-329181737
   PubMed Web of Science ®Google Scholar
• ZhouQ, YuQ, GongY, et al. Construction of a lncRNA-miRNA-mRNA network to determine the regulatory roles of lncRNAs in psoriasis. Exp Ther Med. 2019;18(5):4011–4021. doi:10.3892/etm.2019.803531611939
   PubMed Web of Science ®Google Scholar
• WangC, ZongJ, LiY, WangX, DuW, LiL. MiR-744-3p regulates keratinocyte proliferation and differentiation via targeting KLLN in psoriasis. Exp Dermatol. 2019;28(3):283–291. doi:10.1111/exd.1388830664260
   PubMed Web of Science ®Google Scholar
• GrebJE, GoldminzAM, ElderJT, et al. Psoriasis. Nat Rev Dis Primers. 2016;2(1):16082. doi:10.1038/nrdp.2016.8227883001
   PubMed Web of Science ®Google Scholar
• OgawaE, SatoY, MinagawaA, OkuyamaR. Pathogenesis of psoriasis and development of treatment. J Dermatol. 2018;45(3):264–272. doi:10.1111/1346-8138.1413929226422
   PubMed Web of Science ®Google Scholar
• Di CesareA, Di MeglioP, NestleFO. The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol. 2009;129(6):1339–1350. doi:10.1038/jid.2009.5919322214
   PubMed Web of Science ®Google Scholar
• KupetskyEA, MathersAR, FerrisLK. Anti-cytokine therapy in the treatment of psoriasis. Cytokine. 2013;61(3):704–712. doi:10.1016/j.cyto.2012.12.02723410503
   PubMed Web of Science ®Google Scholar
• FengS, WangL, LiuW, ZhongY, XuS. MiR-126 correlates with increased disease severity and promotes keratinocytes proliferation and inflammation while suppresses cells’ apoptosis in psoriasis. J Clin Lab Anal. 2018;32(9):e22588. doi:10.1002/jcla.2258829943471
   PubMed Web of Science ®Google Scholar
• HanR, Rostami-YazdiM, GerdesS, MrowietzU. Triptolide in the treatment of psoriasis and other immune-mediated inflammatory diseases. Br J Clin Pharmacol. 2012;74(3):424–436. doi:10.1111/j.1365-2125.2012.04221.x22348323
   PubMed Web of Science ®Google Scholar
• HuangL, FengS, WangH. Decreased bone mineral density in female patients with systemic lupus erythematosus after long-term administration of Tripterygium Wilfordii Hook. F. Chin Med J. 2000;113(2):159–161.11775543
   PubMed Web of Science ®Google Scholar
• LvQW, ZhangW, ShiQ, et al. Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial. Ann Rheum Dis. 2015;74(6):1078–1086. doi:10.1136/annrheumdis-2013-20480724733191
   PubMed Web of Science ®Google Scholar
• WangX, MattaR, ShenG, NelinLD, PeiD, LiuY. Mechanism of triptolide-induced apoptosis: effect on caspase activation and Bid cleavage and essentiality of the hydroxyl group of triptolide. J Mol Med. 2006;84(5):405–415. doi:10.1007/s00109-005-0022-416385419
   PubMed Web of Science ®Google Scholar
• LiP, YangX, YangY, et al. Synergistic effect of all-trans-retinal and triptolide encapsulated in an inflammation-targeted nanoparticle on collagen-induced arthritis in mice. J Control Release. 2019.
   Web of Science ®Google Scholar
• SongJM, MollaK, AnandharajA, et al. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling. Oncotarget. 2017;8(16):26927–26940. doi:10.18632/oncotarget.1587928460475
   PubMedGoogle Scholar
• HongqinT, XinyuL, HengG, LanfangX, YongfangW, ShashaS. Triptolide inhibits IFN-gamma signaling via the Jak/STAT pathway in HaCaT keratinocytes. Phytother Res. 2011;25(11):1678–1685. doi:10.1002/ptr.347121433155
   PubMed Web of Science ®Google Scholar
• HuangRY, LiL, WangMJ, ChenXM, HuangQC, LuCJ. An exploration of the role of MicroRNAs in psoriasis: a systematic review of the literature. Medicine. 2015;94(45):e2030. doi:10.1097/MD.000000000000203026559308
   PubMed Web of Science ®Google Scholar
• IveyKN, SrivastavaD. microRNAs as developmental regulators. Cold Spring Harb Perspect Biol. 2015;7(7):a008144. doi:10.1101/cshperspect.a00814426134312
   PubMed Web of Science ®Google Scholar
• ShenoyA, BlellochRH. Regulation of microRNA function in somatic stem cell proliferation and differentiation. Nat Rev Mol Cell Biol. 2014;15(9):565–576. doi:10.1038/nrm385425118717
   PubMed Web of Science ®Google Scholar
• ZhengY, CaiB, LiX, LiD, YinG. MiR-125b-5p and miR-181b-5p inhibit keratinocyte proliferation in skin by targeting Akt3. Eur J Pharmacol. 2019;862:172659.31518563
   PubMed Web of Science ®Google Scholar
• ShenH, ZengB, WangC, et al. MiR-330 inhibits IL22-induced keratinocyte proliferation through targeting CTNNB1. Biomed Pharmacother. 2017;91:803–811. doi:10.1016/j.biopha.2017.05.00528501007
   PubMed Web of Science ®Google Scholar
• TangL, HeS, ZhuY, et al. Downregulated miR-187 contributes to the keratinocytes hyperproliferation in psoriasis. J Cell Physiol. 2019;234(4):3661–3674. doi:10.1002/jcp.2713530607907
   PubMed Web of Science ®Google Scholar
• WangR, WangFF, CaoHW, YangJY. MiR-223 regulates proliferation and apoptosis of IL22-stimulated HaCat human keratinocyte cell lines via the PTEN/Akt pathway. Life Sci. 2019;230:28–34. doi:10.1016/j.lfs.2019.05.04531108094
   PubMed Web of Science ®Google Scholar
• BoxemM. Cyclin-dependent kinases in C. elegans. Cell Div. 2006;1(1):6. doi:10.1186/1747-1028-1-616759361
   PubMed Web of Science ®Google Scholar
• LiW, SankiA, KarimRZ, et al. The role of cell cycle regulatory proteins in the pathogenesis of melanoma. Pathology. 2006;38(4):287–301. doi:10.1080/0031302060081795116916716
   PubMed Web of Science ®Google Scholar
• ArulS, DayalanH, JegadeesanM, DamodharanP. Induction of differentiation in psoriatic keratinocytes by propylthiouracil and fructose. BBA Clin. 2016;6:82–86. doi:10.1016/j.bbacli.2016.06.00227453822
   PubMedGoogle Scholar
• ChandraA, RayA, SenapatiS, ChatterjeeR. Genetic and epigenetic basis of psoriasis pathogenesis. Mol Immunol. 2015;64(2):313–323. doi:10.1016/j.molimm.2014.12.01425594889
   PubMed Web of Science ®Google Scholar
• PengC, ZhangS, LeiL, et al. Epidermal CD147 expression plays a key role in IL22-induced psoriatic dermatitis. Sci Rep. 2017;7(1):44172. doi:10.1038/srep4417228272440
   PubMed Web of Science ®Google Scholar
• HaoJQ. Targeting interleukin-22 in psoriasis. Inflammation. 2014;37(1):94–99. doi:10.1007/s10753-013-9715-y23978911
   PubMed Web of Science ®Google Scholar
• WangW, YuX, WuC, JinH. IL-36gamma inhibits differentiation and induces inflammation of keratinocyte via Wnt signaling pathway in psoriasis. Int J Med Sci. 2017;14(10):1002–1007. doi:10.7150/ijms.2080928924372
   PubMed Web of Science ®Google Scholar
• SunS, ZhangX, XuM, et al. Berberine downregulates CDC6 and inhibits proliferation via targeting JAK-STAT3 signaling in keratinocytes. Cell Death Dis. 2019;10(4):274.30894513
   PubMed Web of Science ®Google Scholar
• JooJH, HongIK, KimNK, ChoiE. Trichosanthes kirilowii extract enhances repair of UVB radiation induced DNA damage by regulating BMAL1 and miR1423p in human keratinocytes. Mol Med Rep. 2018;17(1):877–883. doi:10.3892/mmr.2017.793229115465
   PubMed Web of Science ®Google Scholar
• ManicumT, NiF, YeY, FanX, ChenBC. Prognostic values of E2F mRNA expression in human gastric cancer. Biosci Rep. 2018;38(6). doi:10.1042/BSR20181264
   PubMed Web of Science ®Google Scholar
• JiangY, YimSH, XuHD, et al. A potential oncogenic role of the commonly observed E2F5 overexpression in hepatocellular carcinoma. World J Gastroenterol. 2011;17(4):470–477. doi:10.3748/wjg.v17.i4.47021274376
   PubMed Web of Science ®Google Scholar
• WongCF, BarnesLM, DahlerAL, et al. E2F modulates keratinocyte squamous differentiation: implications for E2F inhibition in squamous cell carcinoma. J Biol Chem. 2003;278(31):28516–28522. doi:10.1074/jbc.M30124620012754218
   PubMed Web of Science ®Google Scholar